Andrea Tan
Stock Analyst at Goldman Sachs
(1.97)
# 3,070
Out of 5,127 analysts
52
Total ratings
42.5%
Success rate
-7.3%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andrea Tan
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Maintains: Neutral | $50 → $85 | $65.00 | +30.77% | 3 | Jan 7, 2026 | |
| INSM Insmed | Maintains: Buy | $258 → $225 | $170.27 | +32.14% | 15 | Dec 18, 2025 | |
| IOVA Iovance Biotherapeutics | Maintains: Buy | $16 → $8 | $2.61 | +206.51% | 7 | May 12, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Neutral | $46 → $51 | $78.21 | -34.79% | 4 | May 5, 2025 | |
| DAWN Day One Biopharmaceuticals | Maintains: Buy | $39 → $27 | $9.25 | +191.89% | 6 | Mar 25, 2025 | |
| SGMT Sagimet Biosciences | Maintains: Neutral | $23 → $6 | $5.57 | +7.72% | 5 | Jul 1, 2024 | |
| RLMD Relmada Therapeutics | Downgrades: Sell | $3 → $2 | $4.43 | -54.85% | 3 | Jun 5, 2024 | |
| KOD Kodiak Sciences | Reinstates: Sell | $2 | $26.62 | -92.49% | 1 | Dec 11, 2023 | |
| KRYS Krystal Biotech | Initiates: Buy | $160 | $248.91 | -35.72% | 1 | Nov 20, 2023 | |
| ABCL AbCellera Biologics | Maintains: Buy | $27 → $24 | $4.11 | +483.94% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sell | $10 → $4 | $1.06 | +277.36% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $178 → $375 | $556.22 | -32.58% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $120 → $80 | $12.78 | +525.98% | 2 | May 24, 2022 |
Arrowhead Pharmaceuticals
Jan 7, 2026
Maintains: Neutral
Price Target: $50 → $85
Current: $65.00
Upside: +30.77%
Insmed
Dec 18, 2025
Maintains: Buy
Price Target: $258 → $225
Current: $170.27
Upside: +32.14%
Iovance Biotherapeutics
May 12, 2025
Maintains: Buy
Price Target: $16 → $8
Current: $2.61
Upside: +206.51%
Tarsus Pharmaceuticals
May 5, 2025
Maintains: Neutral
Price Target: $46 → $51
Current: $78.21
Upside: -34.79%
Day One Biopharmaceuticals
Mar 25, 2025
Maintains: Buy
Price Target: $39 → $27
Current: $9.25
Upside: +191.89%
Sagimet Biosciences
Jul 1, 2024
Maintains: Neutral
Price Target: $23 → $6
Current: $5.57
Upside: +7.72%
Relmada Therapeutics
Jun 5, 2024
Downgrades: Sell
Price Target: $3 → $2
Current: $4.43
Upside: -54.85%
Kodiak Sciences
Dec 11, 2023
Reinstates: Sell
Price Target: $2
Current: $26.62
Upside: -92.49%
Krystal Biotech
Nov 20, 2023
Initiates: Buy
Price Target: $160
Current: $248.91
Upside: -35.72%
AbCellera Biologics
Aug 4, 2023
Maintains: Buy
Price Target: $27 → $24
Current: $4.11
Upside: +483.94%
Jan 9, 2023
Maintains: Sell
Price Target: $10 → $4
Current: $1.06
Upside: +277.36%
Dec 20, 2022
Maintains: Buy
Price Target: $178 → $375
Current: $556.22
Upside: -32.58%
May 24, 2022
Maintains: Neutral
Price Target: $120 → $80
Current: $12.78
Upside: +525.98%